全球家庭輸液治療市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

家庭輸液治療市場預計將從 2025 年的 209.6 億美元成長到 2034 年的 390.9 億美元，2026 年至 2034 年的複合年成長率為 7.17%。

隨著醫療系統日益認知到在患者家中提供護理的益處，家庭輸液治療市場需求正經歷快速成長。這項轉變的促進因素包括慢性病盛行率的上升、人口老化以及住院費用的增加。居家輸液治療為患者提供了一種有效的選擇，使他們能夠接受必要的治療，例如抗生素、化療和疼痛管理，同時最大限度地減少住院次數。居家照護的便利性和舒適性對患者和醫療服務提供者都極具吸引力，預計市場將顯著成長。

技術創新正在顯著改善居家輸液治療環境。攜帶式輸液設備和智慧技術解決方案的開發，使居家治療更加安全高效。這些創新使醫護人員能夠遠端監測患者，確保患者遵循治療通訊協定，並在必要時及時介入。此外，遠端醫療服務的整合促進了病患與醫護人員之間的溝通，進一步提升了醫療品質。隨著技術的不斷發展，在患者參與度提高和治療效果改善的推動下，居家輸液治療市場預計將持續成長。

此外，在旨在促進以病人為中心的照護和降低醫療成本的政策推動下，居家輸液治療的法規環境正日趨有利。隨著有利於居家治療的報銷模式不斷發展，醫療服務提供者更有可能投資於居家輸液服務。人們對居家照護效益的認知不斷提高，加上技術進步和支持性法規的訂定，預計將在未來幾年推動居家輸液治療市場的發展。

目錄

第1章 引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 繪製滲透率和成長前景圖
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制
  • 市場機遇
  • 市場問題
• 波特五力分析
• PESTLE分析

4. 全球家庭輸液治療市場（依產品類型分類）

• 市場分析、洞察與預測
• 點滴幫浦
• 靜脈注射裝置
• 靜脈插管
• 無針頭連接器

5. 全球家庭輸液治療市場（依應用分類）

• 市場分析、洞察與預測
• 化療
• 糖尿病
• 水療法
• 疼痛管理
• 移植後治療
• 腸外營養療法
• 其他

6. 全球家庭輸液治療市場（依地區分類）

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第7章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商格局（基於現有資訊）
• 策略規劃

第8章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Baxter International Inc
  • B. Braun Melsungen AG
  • Fresenius Kabi AG
  • Smiths Medical
  • CareCentrix Inc
  • Coram CVS/Specialty Infusion Services
  • Option Care Health Inc
  • CVS Health
  • UnitedHealth Group（Optum）
  • McKesson Corporation
  • PharMerica Corporation
  • BioScrip Inc
  • MedicoRx Specialty Pharmacy
  • InfuSystem
  • Diplomat Pharmacy Inc

The Home Infusion Therapy Market size is expected to reach USD 39.09 Billion in 2034 from USD 20.96 Billion (2025) growing at a CAGR of 7.17% during 2026-2034.

The home infusion therapy market is experiencing a surge in demand as healthcare systems increasingly recognize the benefits of delivering care in the comfort of patients' homes. This shift is driven by the growing prevalence of chronic diseases, the aging population, and the rising costs associated with hospital stays. Home infusion therapy offers a viable alternative, allowing patients to receive necessary treatments, such as antibiotics, chemotherapy, and pain management, while minimizing hospital visits. The convenience and comfort of home-based care are appealing to both patients and healthcare providers, positioning this market for substantial growth.

Technological advancements are significantly enhancing the home infusion therapy landscape. The development of portable infusion devices and smart technology solutions is improving the safety and efficiency of home-based treatments. These innovations enable healthcare professionals to monitor patients remotely, ensuring adherence to treatment protocols and timely interventions when necessary. Additionally, the integration of telehealth services is facilitating better communication between patients and healthcare providers, further enhancing the quality of care. As technology continues to evolve, the home infusion therapy market is expected to expand, driven by increased patient engagement and improved treatment outcomes.

Moreover, the regulatory environment is becoming more supportive of home infusion therapy, with policies aimed at promoting patient-centered care and reducing healthcare costs. As reimbursement models evolve to favor home-based treatments, healthcare providers are more likely to invest in home infusion services. The growing awareness of the benefits of home care, coupled with advancements in technology and supportive regulations, positions the home infusion therapy market for robust growth in the coming years.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

• Infusion Pumps
• Intravenous Set
• IV Cannulas
• Needleless Connectors

By Application

• Chemotherapy
• Diabetes
• Hydration Therapy
• Pain Management
• Post-transplant Therapies
• Parenteral Nutrition Therapy
• Others

COMPANIES PROFILED

• Baxter International Inc, B Braun Melsungen AG, Fresenius Kabi AG, Smiths Medical, CareCentrix Inc, Coram CVSspecialty infusion services, Option Care Health Inc, CVS Health, UnitedHealth Group Optum, McKesson Corporation, PharMerica Corporation, BioScrip Inc, MedicoRx Specialty Pharmacy, InfuSystem, Diplomat Pharmacy Inc

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL HOME INFUSION THERAPY MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Infusion Pumps Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Intravenous Set Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. IV Cannulas Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Needleless Connectors Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL HOME INFUSION THERAPY MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Chemotherapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Diabetes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Hydration Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Pain Management Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Post-transplant Therapies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Parenteral Nutrition Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.8. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL HOME INFUSION THERAPY MARKET: BY REGION 2022-2034(USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Product Type
  • 6.2.2 By Application
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Product Type
  • 6.3.2 By Application
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Product Type
  • 6.4.2 By Application
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Product Type
  • 6.5.2 By Application
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 South East Asia
  • 6.5.8 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Product Type
  • 6.6.2 By Application
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL HOME INFUSION THERAPY INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Baxter International Inc
  • 8.2.2 B. Braun Melsungen AG
  • 8.2.3 Fresenius Kabi AG
  • 8.2.4 Smiths Medical
  • 8.2.5 CareCentrix Inc
  • 8.2.6 Coram CVS/Specialty Infusion Services
  • 8.2.7 Option Care Health Inc
  • 8.2.8 CVS Health
  • 8.2.9 UnitedHealth Group (Optum)
  • 8.2.10 McKesson Corporation
  • 8.2.11 PharMerica Corporation
  • 8.2.12 BioScrip Inc
  • 8.2.13 MedicoRx Specialty Pharmacy
  • 8.2.14 InfuSystem
  • 8.2.15 Diplomat Pharmacy Inc